Home›Clinical trials›Arkansas

GLP-1 clinical trials in Arkansas: 6 recruiting now

7 sites in 2 Arkansas cities. Registry checked October 2, 2026.

Screening for a study can take weeks. Two cash programs to check.

No insurance needed.

  1. Shed$199 a month30% off first month with code Shed10compounded semaglutideCheck price →A health form first, then you choose your plan
  2. Found$289 a monthcompounded semaglutideCheck price →Each plan shows a monthly cash price

Weight-loss studies (2)

Weight-loss study of cagrisema

Where: Little Rock

What: Tests whether a study medicine from Novo Nordisk, cagrisema, can help people with type 2 diabetes lose weight.

Free to join

Who can join: Adults 18+ with obesity, BMI 35+.

Study record on ClinicalTrials.gov

Arkansas Clinical Research, Little Rock

Woodland Int. Research Group, Little Rock

Weight-loss study of KAI-9531

Where: Little Rock

What: Tests whether an investigational medicine from Kailera, KAI-9531, can help people lose weight.

Free to join

Who can join: Adults 18+ with obesity, BMI 35+.

Study record on ClinicalTrials.gov

Kailera Clinical Site, Little Rock

Type 2 diabetes studies (1)

Type 2 diabetes study of survodutide

Where: Little Rock

What: Tests whether a GLP-1 and glucagon medicine from Boehringer Ingelheim, survodutide, can help people with type 2 diabetes lower blood sugar.

Free to join

Who can join: Adults 18+ with type 2 diabetes, BMI 23+.

Call the site: 833-602-2368Study record on ClinicalTrials.gov

Woodland International Research Group, Inc., Little Rock. 833-602-2368

Other GLP-1 studies in Arkansas (3)

Fatty liver disease (MASLD) study of retatrutide

Where: North Little Rock

What: Tests whether a GLP-1, GIP and glucagon medicine from Lilly, retatrutide, can help people reduce liver fat.

Free to join

Who can join: Adults 18+ with fatty liver disease (MASLD), BMI 25+.

Study record on ClinicalTrials.gov

Arkansas Gastroenterology - North Little Rock, North Little Rock

Fatty liver disease (also called MASH or NASH) study of pemvidutide

Where: North Little Rock

What: Tests whether a GLP-1 and glucagon medicine from Altimmune, pemvidutide, can help people reduce liver fat.

Free to join

Who can join: Adults 18 to 75 with fatty liver disease (also called MASH or NASH), BMI 23+.

Study record on ClinicalTrials.gov

Altimmune Clinical Study Site, North Little Rock

Pre-op gastric emptying study

Where: Little Rock

Free to join

Who can join: Adults 18+.

Study record on ClinicalTrials.gov

University of Arkansas for Medical Science, Little Rock

Source: ClinicalTrials.gov, the federal registry, read October 2, 2026. Open a study's registry record before you call: it can close to new participants at any time. GLP Chart does not enroll anyone, is not paid for clinical-trial referrals and has no relationship with any sponsor or site on this page.

Clinical trials by state

Every state with a GLP-1 study recruiting today. 48 of them.

John Samaras, editor of GLP Chart
Written and edited by John SamarasAbout this siteContact
Why you can trust GLP Chart. Same scoring framework applied to every program. No paid placements. We never remove unfavorable information at an advertiser's request. Pricing is pulled from each program's public-facing page every Monday.